Matthieu holds a doctorate in biotechnology. He has joined Nanobiotix in 2004. With over 15 years in nanomedicine, he is the author of more than 15 publications and scientific communications and is the inventor of 15 patents. He has held multiple positions in Nanobiotix before taking the lead at Curadigm and managed both domestic and international projects.
Laurent Levy is the co-founder of Nanobiotix and has served as our Chief Executive Officer since March 2003. He was first appointed as Chairman of the executive board of the Company on May 27, 2004. He has extensive experience in sciences and techniques related to nanotechnologies. His research at the frontier of biotechnology and nanotechnologies has resulted in the development of a number of concrete applications such as NBTXR3, which could open a new method for cancer treatment.